Pricing Log in Create free account

Cardio Diagnostics Holdings, Inc. (CDIO) vs Heatwurx Inc. (PCSA)

Cardio Diagnostics Holdings, Inc. and Heatwurx Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Heatwurx Inc. are of similar size ($5.2M and $5.1M). Cardio Diagnostics Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Cardio Diagnostics Holdings, Inc. grew revenue faster over the last twelve months: −25.1% against −34.5%. Heatwurx Inc. has the higher net margin (0.00% vs −44,312.3%) and the higher return on invested capital (0.00% vs −219.4%). Across the 15 metrics below, Heatwurx Inc. leads on 8 and Cardio Diagnostics Holdings, Inc. on 7.

Valuation

Metric CDIO PCSA Biotechnology median
P/E n/m 1.75 8.58
P/S 344.60 38.64 10.29
P/B 0.68 n/m 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.09 n/m 0.67
EV/Sales (38.05) 48.44 9.89
Earnings yield (171.76%) 57.14% (31.56%)
Free cash flow yield (115.77%) (259.68%) (23.42%)

Profitability

Metric CDIO PCSA Biotechnology median
Gross margin 100.00% 0.00% 65.77%
Operating margin (44,230.82%) 0.00% 0.00%
Net margin (44,312.33%) 0.00% 0.00%
Free cash flow margin (39,893.15%) 0.00% 0.00%
Return on equity (75.44%) (464.19%) (54.09%)
Return on assets (70.62%) (262.17%) (47.78%)
Return on invested capital (219.40%) 0.00% 0.00%

Growth

Metric CDIO PCSA Biotechnology median
Revenue growth (TTM) (25.13%) (34.50%) 5.83%
EPS growth (last fiscal year) 60.15% 89.29% 29.36%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDIO PCSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.15 0.87 4.80
Net debt to EBITDA 0.84 0.40 0.97

Dividend

Metric CDIO PCSA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric CDIO PCSA Biotechnology median
Market cap 5.05m 5.20m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack